Skip to content

Development and Effectiveness of an Integrated Management Program for Metabolic Syndrome

Development and longitudinal effect of a stage-matched PACE-MAP program for improving therapeutic adherence trajectories and health outcomes in adults at risk for metabolic syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011681
Enrollment
120
Registered
2026-03-05
Start date
2024-05-20
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : The intervention group will participate in an integrated health management program based on the 16-week PACE-MAP program including 150 minutes or more of physical activity per week and me

Sponsors

Ajou University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Individuals diagnosed with diabetes (E11), hypertension (I10-I15), or lipid metabolism disorders (E78), who have been taking at least one medication (such as fibrates or statins) for diabetes, hypertension, or lipid disorders for a minimum of four weeks, and who meet at least one criterion of the NCEP-ATP III metabolic syndrome diagnostic criteria.

Exclusion criteria

Exclusion criteria: Individuals who have undergone Percutaneous Transluminal Coronary Angioplasty (PTCA) or Coronary Artery Bypass Grafting (CABG) within the last six months, have severe renal disease (eGFR < 30 ml/min), have heart function classified as NYHA III-IV, have been diagnosed with and are receiving treatment for malignant tumors within the last five years, are organ transplant recipients or are taking immunosuppressants, have cardiovascular or musculoskeletal conditions that absolutely contraindicate exercise, or are participating in other clinical trials or treatments at the time of screening.

Design outcomes

Primary

MeasureTime frame
Health outcome - HRQoL;Health outcome-CardioMetabolic Risks

Secondary

MeasureTime frame
Treatment adherence ;Socio-psychological model factors (IMB etc), demographic, disease characteristics;Depressive symptoms;Participation Experiences

Countries

Korea, Republic of

Contacts

Public ContactChun-Ja Kim

Ajou University

ckimha@ajou.ac.kr+82-31-219-7017

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 14, 2026